Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $490.0M |
| Sales growthchange from the year before | +3.6% |
| Operating marginshare of sales left after running the business | 8.6% |
| Net marginshare of sales kept as profit | 5.4% |
| Free-cash-flow marginspare cash generated per $100 of sales | 5.2% |
| Return on invested capitalprofit made on each $100 put into the business | 9.7% |
| Return on equityprofit vs. shareholders' accounting value | 9.1% |
| Debt / equitydebt vs. shareholders' accounting value | 0.18 |
| Change in share countnegative = the company is buying back its shares | -2.1% |
1 insider sold $1.8M on the open market.
| Biglari, Sardar; Biglari Capital Corp.; Lion Fund Ii, L.P.; Biglari Holdings Inc.; Biglari Reinsurance Ltd.; Biglari Insurance Group Inc.10% owner; Other | SoldAug 5 | 80,000 shat $16.90 · $1.4M |
| Biglari, Sardar; Biglari Capital Corp.; Lion Fund Ii, L.P.; Biglari Holdings Inc.; Biglari Reinsurance Ltd.; Biglari Insurance Group Inc.10% owner; Other | SoldAug 3 | 20,000 shat $16.73 · $335K |
| Biglari, Sardar; Biglari Capital Corp.; Lion Fund Ii, L.P.; Biglari Holdings Inc.; Biglari Reinsurance Ltd.; Biglari Insurance Group Inc.10% owner; Other | SoldJul 30 | 546 shat $16.70 · $9K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy